Lv71
3760 积分 2024-04-11 加入
Senescence-associated metabolic alterations aggravate calcific aortic valve disease
30天前
已完结
A Bibliometric Analysis of Immunotherapy in Diffuse Large B-Cell Lymphoma from 2004 to 2024
1个月前
已完结
Electrostatic gating synergizing with size sieving: A MOF-Based nanofiltration membrane for mitigating the permeability-selectivity trade-off in lithium recovery
2个月前
已完结
CCT2 regulates the proliferation, apoptosis, and cell cycle arrest of multiple myeloma cells through the P53 signalling pathway
2个月前
已关闭
CD38-Targeted Small-Molecule PET Radiotracer for Noninvasive Tumor Evaluation and Preliminary Therapy Monitoring in Multiple Myeloma
5个月前
已完结
Efficacy and Safety of Zanubrutinib in B-Cell Malignancies: A Single-Arm Meta-Analysis
5个月前
已关闭
A Bibliometric Analysis of Immunotherapy in Diffuse large B-cell lymphoma from 2004 to 2024
5个月前
已完结
Serum metabolomics reveals the effects of accompanying treatment on fatigue in patients with multiple myeloma
5个月前
已完结
Cognitive Deficits and Delayed Neuronal Loss in a Mouse Model of Multiple Microinfarcts
5个月前
已完结
The effect of immunomodulatory drugs on bone metabolism of patients with multiple myeloma
6个月前
已完结
Triplet regimens for all: genomically agnostic approaches to improve on HMA + VEN in AML?
8个月前
已采纳
Targeted triplet therapies incorporating FLT3 or IDH inhibitors: ready for prime time?
8个月前
已采纳
Could treatment modification based on early response assessment improve results in DLBCL?
8个月前
已采纳
Emerging immunotherapy advances for non-Hodgkin lymphomas: engaging T cells in the fight
8个月前
已采纳
Where do immunotherapies stand in management of acute leukemia in adults?
8个月前
已采纳
Gene transfer and genome editing of T cells for cancer immunotherapy: from allogeneic HSCT to TCR gene editing
8个月前
已采纳
(Un) Diagnosing von Willebrand disease
8个月前
已采纳
Update in the diagnosis of complement-mediated thrombotic microangiopathy/atypical hemolytic uremic syndrome
8个月前
已采纳
Update in the diagnosis of complement-mediated thrombotic microangiopathy/atypical hemolytic uremic syndrome
8个月前
已采纳
Molecular subtypes of DLBCL: are we ready to translate our knowledge into the change of treatment paradigms?
8个月前
已采纳
皖公网安备34019202002308
